Cargando…
Harnessing Liposome Interactions With the Immune System for the Next Breakthrough in Cancer Drug Delivery
Liposomal nanoparticles are a heterogeneous group of engineered drug carriers that have tremendous therapeutic potential in the treatment of cancer. They increase tumor drug delivery, significantly attenuate drug toxicity, and protect the drug from degradation. However, two decades after approval of...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422978/ https://www.ncbi.nlm.nih.gov/pubmed/30914953 http://dx.doi.org/10.3389/fphar.2019.00220 |